The use of external controls: To what extent can it currently be recommended?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The use of external controls: To what extent can it currently be recommended?
Authors
Keywords
-
Journal
PHARMACEUTICAL STATISTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-28
DOI
10.1002/pst.2120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current statistical considerations and regulatory perspectives on the planning of confirmatory basket, umbrella and platform trials
- (2020) Olivier Collignon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Are cancer patients better off if they participate in clinical trials? A mixed methods study
- (2020) Zandra Engelbak Nielsen et al. BMC CANCER
- Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer
- (2019) Sandra D. Griffith et al. ADVANCES IN THERAPY
- Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control
- (2019) Annette Kopp‐Schneider et al. BIOMETRICAL JOURNAL
- A multistate model for early decision‐making in oncology
- (2019) Ulrich Beyer et al. BIOMETRICAL JOURNAL
- Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials
- (2019) Gillis Carrigan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation
- (2019) Hans‐Georg Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trial designs using real‐world data: The changing landscape of the regulatory approval process
- (2019) Elodie Baumfeld Andre et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials
- (2018) Jessica Lim et al. Therapeutic Innovation & Regulatory Science
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Including historical data in the analysis of clinical trials: Is it worth the effort?
- (2017) Joost van Rosmalen et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record
- (2016) Benjamin A. Goldstein et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- “Threshold-crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
- (2016) H-G Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficiencies of platform clinical trials: A vision of the future
- (2016) Benjamin R Saville et al. Clinical Trials
- Increasing value and reducing waste in biomedical research: who's listening?
- (2016) David Moher et al. LANCET
- Mediation analysis of the relationship between institutional research activity and patient survival
- (2014) Justine Rochon et al. BMC Medical Research Methodology
- How to increase value and reduce waste when research priorities are set
- (2014) Iain Chalmers et al. LANCET
- Knowledge translation of research findings
- (2012) Jeremy M Grimshaw et al. Implementation Science
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started